PEN
Penumbra Inc (PEN)
Healthcare • NYSE • $317.63+0.45%
- Symbol
- PEN
- Exchange
- NYSE
- Sector
- Healthcare
- Industry
- Medical Devices
- Price
- $317.63
- Daily Change
- +0.45%
- Market Cap
- $12.48B
- Trailing P/E
- 72.92
- Forward P/E
- 50.49
- 52W High
- $362.41
- 52W Low
- $221.26
- Analyst Target
- $363.36
- Dividend Yield
- N/A
- Beta
- 0.70
Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX, BENCHMARK, BMX, DDC, Access25; MIDWAY, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization device, aspiration tubing, aspiration pump, and ot…
Company websiteResearch PEN on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.